Compare Planet Labs (PL) vs TG Therapeutics Inc (TGTX) Price & Performance

Planet LabsTrade

TG Therapeutics IncTrade

Price performance (Past 24H)

Key statistics

Planet Labs vs TG Therapeutics Inc — how do they compare? Planet Labs trades at $16.61 (market cap $6.25B), while TG Therapeutics Inc trades at $55.15 (market cap $8.16B). The key difference: TG Therapeutics Inc is the larger of the two by market cap, and TG Therapeutics Inc is trading nearer its 52-week high, Planet Labs nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Planet Labs for 4 Days and TG Therapeutics Inc for 15 Days on average.

	PL	TGTX
Market Cap	$6.25B	$8.16B
Volume	19,125,340	1,735,121
Sector	Industrials	Health
52-Week High	$51.40	$59.06
52-Week Low	$11.16	$26.94
Typical Hold Time	4 Days	15 Days
Enterprise Value	$5.89B	$8.37B

View details →View details →

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Planet Labs

No Aura AI signal available yet.

TG Therapeutics Inc

TG Therapeutics (TGTX) trades at $54.96, up 3.8% with strong fundamentals including 82.37% gross margins and 100.28% ROE, though recent earnings misses and a negative cash flow of -$100.70M in 2025 raise concerns. Technical indicators show bearish momentum with support at $51-$52, while news highlights BRIUMVI's market share gains and potential acquisition interest.

The outlook remains mixed: analyst consensus is bullish with an $80.50 price target, but risks include ongoing litigation, earnings volatility, and competitive pressures. Upside potential hinges on BRIUMVI's continued growth and pipeline advancements, making TGTX a high-risk, high-reward biotech play.

Aura AI is an analytical signal, not financial advice — do your own research.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

100% Buy0% Sell

Avg holding period · 4 Days

TGTX

No sentiment data available yet.

Top news

Latest headlines on both assets

AST SpaceMobile shares drop 6% as SpaceX secures low-band spectrum, tightening competition for satellite phone links.24/7 Wall Street · 7 hours agoBearish AST SpaceMobile falls 7% after SpaceX wins FCC approval for direct-to-phone satellite service.24/7 Wall Street · 1 day agoBearish AST SpaceMobile rises 3% as US and Japan support Rakuten satellite deal, boosting space stocks.24/7 Wall Street · 3 days agoBullish View details →

TGTX

View details →

About Planet Labs

Planet Labs operates Earth-imaging satellites and provides geospatial data products. Its imagery and analytics help governments and businesses monitor changes across the planet.

About TG Therapeutics Inc

TG Therapeutics is a fully integrated biopharmaceutical company focused on the acquisition, development, and commercialization of novel treatments for B-cell mediated diseases. Its cornerstone product, BRIUMVI (ublituximab-xiiy), is a glycoengineered monoclonal antibody approved for relapsing forms of multiple sclerosis. The company is currently executing a 'pipeline-in-a-product' strategy, expanding BRIUMVI into new delivery methods and indications while advancing a broader portfolio of autoimmune and oncology candidates.